Atlas Trials

Ketamine for Suicidality in Bipolar Depression

Clinical trial NCT01944293 · COMPLETED

Trial details

NCT number
NCT01944293
Sponsor
New York State Psychiatric Institute
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Bipolar DisorderMajor Depressive EpisodeSuicidal Ideation
Start date
2013-09-01
Primary completion
2017-09-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.